AI-Driven Advances in ATTR-CM Care

Guest: Frederick Ruberg, MD Artificial intelligence has rapidly advanced disease recognition in transthyretin amyloid cardiomyopathy (ATTR-CM), and its role in guiding treatment selection, predicting progression, and refining prognosis is now being explored. Discover what's next in ATTR-CM care with Dr. Frederick Ruberg, Chief of Cardiovascular Medicine at Boston Medical Center and Thomas J. Ryan Professor of Cardiovascular Medicine at Boston University Chobanian & Avedisian School of Medicine.

Episode metadata supplied by the publisher feed · Published Mar 27, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

AI-Driven Advances in ATTR-CM Care

0:00 3:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Heart Matters?

This episode is 3 minutes long.

When was this Heart Matters episode published?

This episode was published on March 27, 2026.

Can I download this Heart Matters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!